Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology (Q33957431)

30 July 2017

1 reference

title

Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology (English)

1 reference

30 July 2017

2

D Gladman

1 reference

30 July 2017

3

D Isenberg

1 reference

30 July 2017

4

M Petri

1 reference

30 July 2017

V Strand

1

1 reference

30 July 2017

J Smolen

series ordinal

5

1 reference

30 July 2017

P Tugwell

series ordinal

6

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

322-327

1 reference

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Treatment of lupus nephritis: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Measurement of systemic lupus erythematosus activity in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Oral contraceptives and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Clinical rheumatologic applications of reproductive immunology. Facts, fiction, and fancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Impact of disease activity and cumulative damage on the health of lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Psychiatric symptoms in systemic lupus erythematosus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120300678828424

10.1191/096120300678828424

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference